GOODWILL AND INTANGIBLE ASSETS

3 Months Ended

Mar. 31, 2012

Notes to Financial Statements [Abstract]

A reconciliation of changes in the Company’s goodwill is as follows:



(in thousands)	Dental Consumable and Laboratory Businesses		Orthodontics/Canada/Mexico/Japan		Select Distribution Businesses		Implants/Endodontics/Healthcare/Pacific Rim			Total

Balance at December 31, 2011	$	484,779	$	107,291	$	111,011	$	1,486,982		$	2,190,063
Revision of provisional amounts on prior acquisition	—		—		—		(144,530		)	(144,530		)
Effects of exchange rate changes	7,822		13		2,861		53,222			63,918
Balance at March 31, 2012	$	492,601	$	107,304	$	113,872	$	1,395,674		$	2,109,451

Identifiable definite-lived and indefinite-lived intangible assets consist of the following:



	March 31, 2012							December 31, 2011
(in thousands)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount

Patents	$	134,648	$	(20,837	)	$	113,811	$	131,252	$	(17,393	)	$	113,859
Trademarks	87,577		(40,524		)	47,053		73,413		(23,885		)	49,528
Licensing agreements	30,759		(17,811		)	12,948		30,444		(17,277		)	13,167
Customer relationships	727,912		(131,643		)	596,269		411,626		(19,066		)	392,560
Total definite-lived	$	980,896	$	(210,815	)	$	770,081	$	646,735	$	(77,621	)	$	569,114

Trademarks	$	219,547	$	—		$	219,547	$	210,675	$	—		$	210,675
In-process R&D	8,910		—			8,910		11,311		—			11,311
Total indefinite-lived	$	228,457	$	—		$	228,457	$	221,986	$	—		$	221,986

Total identifiable intangible assets	$	1,209,353	$	(210,815	)	$	998,538	$	868,721	$	(77,621	)	$	791,100

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details